Effect of ground-glass opacity components on the recurrence of pathological stage IB non-small cell lung cancer harboring epidermal growth factor receptor mutations
Surgery Today · 2025
DOI: 10.1007/s00595-025-03006-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, 2025. Verfasst von Yukio Watanabe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, Juntendo University School of Medicine, 1-3 Hongo 3-Chome, Bunkyo-Ku, Tokyo, 113-8421, Japan. ykwatana@junten…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, ErbB Receptors, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare, Japan, the Smoking Research Foundation, and the National Cancer Center Resear….
Abstract (Originalsprache)
PURPOSE: This study aimed to examine the influence of ground-glass opacity (GGO) on the prognosis of epidermal growth factor receptor (EGFR)-mutated pathological (p)-stage IB non-small cell lung cancer (NSCLC). METHODS: Between 2009 and 2021, 115 patients underwent complete anatomical lung resection with mediastinal lymphadenectomy for p-stage IB non-squamous NSCLC harboring common EGFR mutations. The patients were classified into the part-solid and pure-solid arms based on the presence of GGO components. RESULTS: The median follow-up time was 70.2 months. Sixty-seven patients (58%) had pure-solid tumors and 112 (97%) were diagnosed with adenocarcinoma. No patients received adjuvant EGFR-tyrosine kinase inhibitors (TKIs). The 5-year disease-free survival (DFS) rates in the pure-solid arm were significantly lower than those in the part-solid arm (5-year DFS: 45.3% vs. 86.8%, p < 0.01). The 5-year cumulative incidence of recurrence was higher in the pure-solid arm than that in the part-solid arm (49.9% vs. 9.0%, p < 0.01). A multivariable analysis revealed that pure-solid tumors were an independent prognostic predictor of disease-free survival, whereas pathological factors were not. CONCLUSIONS: In EGFR-mutated p-stage IB NSCLC, pure-solid tumors were significant predictors of DFS. The presence of GGO components should be considered in the decision criteria for adjuvant therapy with TKIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Thoracic Surgery, Juntendo University School of Medicine, 1-3 Hongo 3-Chome, Bunkyo-Ku, Tokyo, 113-8421, Japan. ykwatana@juntendo.ac.jp.
- Department of Human Pathology, Juntendo University School of Medicine, Tokyo, Japan.
- Department of General Thoracic Surgery, Juntendo University School of Medicine, 1-3 Hongo 3-Chome, Bunkyo-Ku, Tokyo, 113-8421, Japan.
Förderung
- Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare, Japan, the Smoking Research Foundation, and the National Cancer Center Resear…
Zitieren
APA
Watanabe, Y., Hayashi, T., Hattori, A., Fukui, M., Matsunaga, T., Tonosaki, M., Takamochi, K., & Suzuki, K. (2025). Effect of ground-glass opacity components on the recurrence of pathological stage IB non-small cell lung cancer harboring epidermal growth factor receptor mutations. Surgery Today. https://doi.org/10.1007/s00595-025-03006-0
Vancouver
Watanabe Y, Hayashi T, Hattori A, Fukui M, Matsunaga T, Tonosaki M, et al. Effect of ground-glass opacity components on the recurrence of pathological stage IB non-small cell lung cancer harboring epidermal growth factor receptor mutations. Surgery Today. 2025. doi:10.1007/s00595-025-03006-0
BibTeX
@article{Watanabe2025,
author = {Watanabe, Yukio and Hayashi, Takuo and Hattori, Aritoshi and Fukui, Mariko and Matsunaga, Takeshi and Tonosaki, Momoko and Takamochi, Kazuya and Suzuki, Kenji},
title = {Effect of ground-glass opacity components on the recurrence of pathological stage IB non-small cell lung cancer harboring epidermal growth factor receptor mutations},
journal = {Surgery Today},
year = {2025},
doi = {10.1007/s00595-025-03006-0}
}
EUVIMED